Revisions for Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors. | Registro Público Cubano de Ensayos Clínicos

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors. has only one revision

Registered Trials

Registration process

About the RPCEC

Useful resources